Tang Capital Management Llc
10% Owner at Boundless Bio, Inc. (BOLD); 10% Owner at Fulcrum Therapeutics, Inc. (FULC)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$51K
Total bought / sold$891K / $54K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 28SEC | BOLDBoundless Bio, Inc. | Sell | 18,3002,840,635 held (−1%) | $2.97 | $54K | -14.8% |
| Jul 15SEC | FULCFulcrum Therapeutics, Inc. | Buy | 12,9666,676,349 held (+0%) | $3.54 | $46K | +6.5% |
| Jul 15SEC | FULCFulcrum Therapeutics, Inc. | Buy | 53,6516,730,000 held (+1%) | $3.56 | $191K | +5.9% |
| Jul 15SEC | FULCFulcrum Therapeutics, Inc. | Buy | 75,9526,805,952 held (+1%) | $3.58 | $272K | +5.3% |
| Jul 15SEC | FULCFulcrum Therapeutics, Inc. | Buy | 107,3776,913,329 held (+2%) | $3.56 | $382K | +5.9% |
- Buy
10% Owner Tang Capital Management Llc bought $46K of FULC at $3.54 — first open-market purchase in our records.
- Buy
10% Owner Tang Capital Management Llc bought $191K of FULC at $3.56 — largest purchase by this insider in our records.
- Buy
10% Owner Tang Capital Management Llc bought $272K of FULC at $3.58 — largest purchase by this insider in our records.
- Buy
10% Owner Tang Capital Management Llc bought $382K of FULC at $3.56 — largest purchase by this insider in our records.